Panton Valentine Leukocidin

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 5739 Experts worldwide ranked by ideXlab platform

Francois Vandenesch - One of the best experts on this subject based on the ideXlab platform.

  • The Staphylococcal Toxin Panton-Valentine Leukocidin Targets Human C5a Receptors
    Cell host & microbe, 2013
    Co-Authors: András N. Spaan, Cédric Badiou, Thomas Henry, Willemien J. M. Van Rooijen, Magali Perret, Piet C. Aerts, Johan Kemmink, Carla J. C. De Haas, Kok P. M. Van Kessel, Francois Vandenesch
    Abstract:

    Panton-Valentine Leukocidin (PVL) is a staphylococcal bicomponent pore-forming toxin linked to severe invasive infections. Target-cell and species specificity of PVL are poorly understood, and the mechanism of action of this toxin in Staphylococcus aureus virulence is controversial. Here, we identify the human complement receptors C5aR and C5L2 as host targets of PVL, mediating both toxin binding and cytotoxicity. Expression and interspecies variations of the C5aR determine cell and species specificity of PVL. The C5aR binding PVL component, LukS-PV, is a potent inhibitor of C5a-induced immune cell activation. These findings provide insight into Leukocidin function and staphylococcal virulence and offer directions for future investigations into individual susceptibility to severe staphylococcal disease.

  • Pragmatic management of Panton-Valentine Leukocidin-associated staphylococcal diseases.
    International journal of antimicrobial agents, 2011
    Co-Authors: Y. Gillet, Jerome Etienne, Francois Vandenesch, Anne Tristan, Oana Dumitrescu, O. Dauwalder, E. Javouhey, D. Floret, Gerard Lina
    Abstract:

    Panton-Valentine Leukocidin (PVL)-producing Staphylococcus aureus is associated with a broad spectrum of diseases, ranging from common uncomplicated soft tissue infections to severe diseases such as complicated soft tissue infections, extensive bone and joint infections, and necrotising pneumonia. Specialised management of infection based on the presence of PVL may not be required for mild infections, whereas it could be lifesaving in other settings. Moreover, most severe PVL diseases are recently identified entities and a 'gold standard' treatment from comparatives studies of different therapeutic options is lacking. Thus, recommendations are based on expert opinions, which are elaborated based on theory, in vitro data and analogies with other toxin-mediated diseases. In this review, we consider the potential need for specialised PVL-based management and, if required, which tools should be used to achieve optimal management.

  • Panton-Valentine Leukocidin-positive Staphylococcus aureus strains are associated with follicular skin infections.
    Dermatology (Basel Switzerland), 2011
    Co-Authors: Pascal Del Giudice, Gerard Lina, Michele Bes, Francois Vandenesch, Thomas Hubiche, Véronique Blanc, Laurent Roudière, Jerome Etienne
    Abstract:

    Background/Aims: Panton-Valentine Leukocidin (PVL)-positive Staphylococcus aureus have been associated with suppurative infections; however, their precise role in

  • Primary Skin Abscesses Are Mainly Caused by Panton-Valentine Leukocidin-Positive Staphylococcus aureus Strains
    Dermatology (Basel Switzerland), 2009
    Co-Authors: Pascal Del Giudice, Gerard Lina, Michele Bes, Francois Vandenesch, Thomas Hubiche, Véronique Blanc, Laurent Roudière, Alexis De Rougemont, Jerome Etienne
    Abstract:

    Background: The role of Panton-Valentine Leukocidin (PVL) in skin and soft-tissue infections is not clear. Objective: Our purpose was to determine the prevalence

  • Panton-Valentine Leukocidin is expressed at toxic levels in human skin abscesses.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2008
    Co-Authors: Cédric Badiou, Jerome Etienne, Yves Gillet, Francois Vandenesch, Oana Dumitrescu, M. Croze, Bruno Dohin, D.h. Slayman, Bernard Allaouchiche, Gerard Lina
    Abstract:

    Pus samples were prospectively collected from patients with Staphylococcus aureus skin infections and tested for Panton-Valentine Leukocidin (PVL). PVL was detected at concentrations that were toxic for rabbit skin in all specimens from patients infected with strains harbouring PVL genes.

Gerard Lina - One of the best experts on this subject based on the ideXlab platform.

Jerome Etienne - One of the best experts on this subject based on the ideXlab platform.

Michele Bes - One of the best experts on this subject based on the ideXlab platform.

  • Panton-Valentine Leukocidin-positive Staphylococcus aureus strains are associated with follicular skin infections.
    Dermatology (Basel Switzerland), 2011
    Co-Authors: Pascal Del Giudice, Gerard Lina, Michele Bes, Francois Vandenesch, Thomas Hubiche, Véronique Blanc, Laurent Roudière, Jerome Etienne
    Abstract:

    Background/Aims: Panton-Valentine Leukocidin (PVL)-positive Staphylococcus aureus have been associated with suppurative infections; however, their precise role in

  • Molecular Epidemiology of Panton-Valentine Leukocidin-Positive Staphylococcus aureus in Spain: Emergence of the USA300 Clone in an Autochthonous Population
    Journal of clinical microbiology, 2010
    Co-Authors: Raquel Blanco, Jerome Etienne, Michele Bes, Anne Tristan, Guillermo Ezpeleta, Anders Rhod Larsen, Ramón Cisterna, Frédéric Laurent
    Abstract:

    We characterized all of the Panton-Valentine Leukocidin (PVL)-positive Staphylococcus aureus isolates collected between 2005 and 2008 in the Bilbao, Spain, area. For the first time, the USA300 clone is reported as predominant among PVL-positive clones in a European autochthonous population, requiring active monitoring of the incidence of USA300 in Spain and throughout Europe.

  • Primary Skin Abscesses Are Mainly Caused by Panton-Valentine Leukocidin-Positive Staphylococcus aureus Strains
    Dermatology (Basel Switzerland), 2009
    Co-Authors: Pascal Del Giudice, Gerard Lina, Michele Bes, Francois Vandenesch, Thomas Hubiche, Véronique Blanc, Laurent Roudière, Alexis De Rougemont, Jerome Etienne
    Abstract:

    Background: The role of Panton-Valentine Leukocidin (PVL) in skin and soft-tissue infections is not clear. Objective: Our purpose was to determine the prevalence

  • factors predicting mortality in necrotizing community acquired pneumonia caused by staphylococcus aureus containing Panton Valentine Leukocidin
    Clinical Infectious Diseases, 2007
    Co-Authors: Philippe Vanhems, Yves Gillet, Gerard Lina, Michele Bes, Francois Vandenesch
    Abstract:

    Background. Necrotizing pneumonia due to Panton-Valentine Leukocidin-producing strains of Staphylococcus aureus is associated with a high mortality rate. We sought factors associated with vital outcome in 50 cases occurring from 1986 through 2005. Methods. We compared the clinical and biological characteristics of 50 patients according to their vital outcome and examined the characteristics of the corresponding S. aureus isolates. Results. The overall mortality rate was 56%, and the median survival time was 10 days. All of the deaths were attributed to S. aureus infection and were secondary to refractory shock and/or respiratory failure. Fatal outcome was associated with classical severity factors, such as the need for mechanical ventilation or inotrope support, and with onset of the acute respiratory distress syndrome. Airway bleeding was strongly associated with fatal outcome (P = .002). Patients who had focal staphylococcal infection before the onset of pneumonia had a significantly lower mortality rate (P = .002). The main biological feature associated with death was leukopenia (P<.001). In multivariate analysis, leukopenia and erythroderma occurring within the first 24 h after admission to the hospital were independently associated with fatal outcome. Erythroderma was not associated with toxic shock syndrome toxin. Conclusions. Airway bleeding, erythroderma, and leukopenia are associated with fatal outcome from Panton-Valentine Leukocidin-positive S. aureus necrotizing pneumonia. More work is needed to develop more efficacious therapy against this highly lethal disease.

  • Effect of Antibiotics on Staphylococcus aureus Producing Panton-Valentine Leukocidin
    Antimicrobial agents and chemotherapy, 2007
    Co-Authors: Oana Dumitrescu, Jerome Etienne, Sandrine Boisset, Yvonne Benito, Michele Bes, Francois Vandenesch, Cédric Badiou, Marie-elisabeth Reverdy, Gerard Lina
    Abstract:

    We examined the capacity of Staphylococcus aureus strains to release Panton-Valentine Leukocidin (PVL) in the presence of antibiotics. No PVL was detected when S. aureus was incubated at inhibitory concentrations, while subinhibitory concentrations of oxacillin enhanced the PVL level; clindamycin, linezolid, and fusidic acid were inhibitory; and vancomycin had roughly no effect.

Frédéric Wallet - One of the best experts on this subject based on the ideXlab platform.